Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PFE
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
PFE
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

PFE Price Prediction Next Week

Based on the provided data and technical analysis, here's the prediction for PFE's stock price next week:

Technical Analysis

  • Current price: $26.31
  • Fibonacci levels show key resistance at $27.34 and support at $26.11
  • RSI(14) at 48.02 indicates neutral momentum
  • MACD shows slight bullish divergence at 0.08

News Sentiment Analysis

  • Recent positive catalysts:

    • Increased shareholder yield rating to 85% by Validea
    • Strong dividend yield of 6.5% near 15-year high
    • Management prioritizes maintaining and growing dividends

  • Negative factors:

    • Upcoming patent expirations for key drugs
    • Inflation Reduction Act impact estimated at $1 billion for 2025

Price Prediction Based on technical indicators and news sentiment:

  • Short-term resistance: $27.34
  • Support level: $26.11
  • Target price range for next week: $26.80-$27.20

Trading Recommendation SELL/SHORT position recommended:

  1. Entry point: Current price $26.31
  2. Take profit: $25.73 (Fibonacci S2)
  3. Stop loss: $27.72 (Fibonacci R2)

Rationale:

  • Technical indicators show weakening momentum
  • Price currently testing resistance levels
  • Negative fundamental catalysts outweigh positive ones in short term
  • Stock trading below both 20-day ($26.53) and 200-day ($27.34) moving averages

Based on the provided data and technical analysis, here's the prediction for PFE's stock price next week:

Technical Analysis

  • Current price: $26.31
  • Fibonacci levels show key resistance at $27.34 and support at $26.11
  • RSI(14) at 48.02 indicates neutral momentum
  • MACD shows slight bullish divergence at 0.08

News Sentiment Analysis

  • Recent positive catalysts:

    • Increased shareholder yield rating to 85% by Validea
    • Strong dividend yield of 6.5% near 15-year high
    • Management prioritizes maintaining and growing dividends

  • Negative factors:

    • Upcoming patent expirations for key drugs
    • Inflation Reduction Act impact estimated at $1 billion for 2025

Price Prediction Based on technical indicators and news sentiment:

  • Short-term resistance: $27.34
  • Support level: $26.11
  • Target price range for next week: $26.80-$27.20

Trading Recommendation SELL/SHORT position recommended:

  1. Entry point: Current price $26.31
  2. Take profit: $25.73 (Fibonacci S2)
  3. Stop loss: $27.72 (Fibonacci R2)

Rationale:

  • Technical indicators show weakening momentum
  • Price currently testing resistance levels
  • Negative fundamental catalysts outweigh positive ones in short term
  • Stock trading below both 20-day ($26.53) and 200-day ($27.34) moving averages

PFE Similar Chart Price Prediction

The price of PFE is predicted to go up 10.89%, based on the high correlation periods with X. The similarity of these two price pattern on the periods is 94.27%.

stocks logo

PFE

stocks logo

X

Up: 10.89%Similarity: 94.27%

PFE Stock Forecast & Prediction For Years 2025, 2026, 2028, 2029 and 2030

Year

PFE Price Forecast($)

Potential Return(%)

2025

26.730

0.530

2026

34.000

27.870

2028

40.000

50.430

2029

35.000

30.160

2030

40.000

48.750

What is PFE stock price prediction 2025 ?

Pfizer's (PFE) stock price is currently $26.73. Analysts project a potential price of $36 by the end of 2025, driven by expected earnings growth of 10-18% and a focus on oncology drugs, supported by its Seagen acquisition. However, political headwinds and flat revenue guidance for 2025 may limit upside momentum.

What is PFE stock price prediction 2026 ?

PFE's stock price in 2026 is projected to reach approximately $34-$36, driven by growth in oncology and specialty care products, alongside cost-cutting measures. Analysts expect earnings growth of 10%-18% in 2025, with new product launches and acquisitions like Seagen supporting revenue expansion. However, risks include patent expirations and broader pharmaceutical industry challenges.

What is PFE stock price prediction 2028 ?

The price prediction for Pfizer (PFE) stock in 2028 is estimated to be around $40-$45. This projection is based on expected growth in its oncology pipeline, cost-cutting measures, and steady dividend payouts, which could attract long-term investors. However, risks such as patent expirations and slower-than-expected revenue growth could limit upside potential.

What is PFE stock price prediction 2029 ?

PFE stock is projected to reach approximately $35-$40 by 2029, driven by its oncology pipeline expansion, steady dividend growth, and cost-cutting measures. The company's focus on innovative drugs and strategic acquisitions, such as Seagen, positions it for long-term revenue growth despite patent expirations. However, macroeconomic factors and regulatory risks could influence this trajectory.

What is PFE stock price prediction 2030 ?

PFE stock is projected to reach approximately $40-$45 by 2030, driven by its oncology pipeline, cost-cutting measures, and consistent dividend growth. The company's focus on new blockbuster drugs and strategic acquisitions, such as Seagen, positions it for steady revenue and earnings growth. However, risks like patent expirations and regulatory challenges could moderate the pace of growth.

PFE Revenue Forecast

PFE EPS Forecast

PFE FAQs

What is bull’s view on PFE?

Pfizer (PFE) is currently trading at $26.60, with analysts showing mixed but generally bullish sentiment. Guggenheim and Truist Securities maintain "Strong Buy" ratings with price targets of $33 and $32, implying 23%-30% upside, driven by oncology growth and cost-cutting measures. However, concerns over declining COVID-related revenues and patent expirations weigh on the stock, keeping its valuation attractive at just 9.1x 2025 earnings estimates.

What is bear's view on PFE?

Pfizer (PFE) currently trades at $26.60, significantly below its target price of $31, reflecting bearish sentiment. The stock faces challenges from declining COVID-19 product sales and patent expirations, limiting near-term growth. Despite a 6.3% dividend yield, concerns over revenue stagnation and high payout ratios weigh on investor confidence.

What is PFE revenue forecast for next quarter？

The market consensus for PFE's revenue in the upcoming quarter is projected to be approximately $14.308B USD.

What is PFE eps forecast for next quarter？

The market consensus for PFE's eps in the upcoming quarter is projected to be approximately $0.722 USD.

PFE VS S&P500

Pfizer's pipeline productivity is improving with several successful recent drug launches. In particular, cardiovascular drug Vyndaqel is a potential game-changer in the rare-disease arena.

Pfizer's strong success in developing a COVID-19 vaccine and treatment is yielding a massive cash windfall.

Pfizer's decision to divest its off-patent division should result in a faster-growing, innovative company.

Ask Intellectia about PFE

PFE Analyst's Forecast

Colin Bristow

UBS

Hold

Price Target

$31 → $29

Upside

+7.97%

UBS lowered the firm's price target on Pfizer to $29 from $31 and keeps a Neutral rating on the shares as part of a broader note on the U.S. Pharmaceuticals and Biotechnology industry. The firm believes BioPharma will find it difficult to outperform against a more uncertain macro backdrop in the short-term, and thinks President-elect Trump will be capable of enacting significant legislative change, and that unpredictability is expected to cast a shadow over the space, the analyst tells investors in a research note. There will be continued uncertainty in the space until there is more clarity on Trump's changes, UBS says.
Tim Anderson

B of A Securities

Hold

Price Target

$29

Upside

+13.41%

Courtney Breen

Bernstein

Hold

Price Target

$32

Upside

+9.31%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free